Omnicell , Inc. (NASDAQ:OMCL), a leading provider of medication management solutions in the healthcare technology sector, has been navigating a complex market environment characterized by both ...

A month has gone by since the last earnings report for Omnicell (OMCL). Shares have lost about 0.4% in that time frame, underperforming the S&P 500. Will the recent negative trend continue leading ...

Shares of healthcare tech company Omnicell (NASDAQ:OMCL) jumped 5.9% in the afternoon session after the company reported impressive preliminary second quarter 2025 and full-year profit guidance ...

Strategic acquisition of leading pharmacy SaaS solutions provider supports the Autonomous Pharmacy vision and expands Omnicell’s Advanced Services portfolio MOUNTAIN VIEW, Calif.--(BUSINESS WIRE ...

Ratings for Omnicell (NASDAQ:OMCL) were provided by 6 analysts in the past three months, showcasing a mix of bullish and bearish perspectives. The following table provides a quick overview of ...

Omnicell has a record of volume growth but volatile profitability and is experiencing poor order visibility. Operating in a competitive market with the healthcare industry under pressure from ...

FORT WORTH, Texas--(BUSINESS WIRE)--Omnicell, Inc. (Nasdaq:OMCL) (“Omnicell” or the “Company”), a leader in transforming the pharmacy and nursing care delivery model, today announced ...

MOUNTAIN VIEW, Calif., Oct. 23, 2017 /PRNewswire/ -- Omnicell, Inc. (NASDAQ: OMCL), a leading provider of medication and supply management solutions and adherence tools for healthcare systems and ...